GET A QUOTE

Inducible Nitric Oxide Synthase (iNOS/NOS2): A Key Player in Immunity and Pathophysiology

Inducible nitric oxide synthase (known as iNOS or NOS2) plays a role, in producing nitric oxide (NO) when the body faces inflammation triggers. In contrast to the nitric oxide synthases (eNOS and nNOS ) found in endothelial cells and neurons respectively iNOS is activated in various cell types during immune responses and health issues.

Structure and Function

The iNOs enzyme belongs to the nitric oxide synthase family. Comprises three variants. Endothelial (eNOs) nNOs) and inducible (iNOs). Encoded by the NOS2 gene on chromosome 17, in humans are domains that make up the iNOs protein structure.

  • The oxygenase domain plays a role, in generating nitric oxide by catalysing the conversion of L-arginine, with oxygen and NADPH.
  • Flavin Mononucleotide (FM). Flavin Adenine Dinucleotide (FAD) Binding Sites are crucial, for facilitating electron transfer, in the process of NO synthesis.
  • The activity of iNos is controlled by calmodulin binding—a messenger protein that binds calcium and boosts iNos performance when there are levels of calcium, inside the cell.

The main role of iNOS is to generate quantities of nitric oxide that functions, as a signalling molecule, in different biological and disease related activities.

Regulation of iNOS Expression

The activity of iNOs is carefully controlled during transcription. Can be triggered by pro inflammatory cytokines and stimuli such as;

Cytokines such, as Interferon gamma (IFNy) tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) play a role, in triggering the expression of iNOs often released during responses and inflammation processes.

Pathogen associated molecular patterns (PAMPs, for short); Elements found in pathogens like lipopolysaccharides (known as LPS) which come from bacteria and can trigger the expression of iNOS by interacting with pattern recognition receptors, like toll receptors (TLRs).

Conditions, like lack of oxygen and increased oxidative stress can also boost the expression of iNos which leads to the production of nitric oxide, in the area.

The production of iNOS is usually brief. Reaches its peak a few hours after being triggered by stimuli This brief duration enables a reaction, to signs of inflammation and prevents prolonged release of NO which could be harmful.

Role in Immune Response

One of the functions of iNOS, in the system is to produce nitric oxide, which serves several critical functions:

The antimicrobial activity of nitric oxide generated by iNOS is powerful, in inhibiting the growth of bacteria and other microorganisms by compromising their structures.

Regulation of inflammation involves the function of iNos derived nitric oxide, in adjusting the body’s response dynamics. Even though it has the ability to amplify inflammation by stimulating the generation of inflammatory cytokines and attracting immune cells an excessive production of nitric oxide could result in tissue harm and long-term inflammation.

Nitric oxide plays a role, in controlling programmed cell death (apoptosis) affecting cells and tissues nearby by acting as a compound that manages different cellular activities, like growth and differentiation alongside ensuring cell survival.

Pathophysiological Implications

Although iNos plays a role, in supporting the systems functions when it operates efficiently. Any disruptions, in its regulation can lead to a range of health issues.

Persistent activation of i NOS has been linked to standing conditions, like rheumatoid arthritis and inflammatory bowel disease (IB D). High levels of NO can cause harm to tissues. Worsen inflammation which plays a role in advancing the disease.

Neurodegenerative conditions, like Alzheimer’s disease and Parkinson’s disease may see a rise in iNos expression triggering production of NO and sparking neuroinflammation The disruption in this process can cause harm to neurons and play a role, in the development of the diseases.

The involvement of iNOs, in cancer is. Influenced by situations. Though NO can trigger cell death in cancer cells it may also support tumor development, blood vessel formation and the spread of cancer to parts of the body. Increased levels of iNOs have been detected in types of tumors hinting at its role, in advancing cancer.

Excessive iNos expression has been associated with diseases, as levels of NO can lead to endothelial dysfunction and contribute to the development of atherosclerosis and hypertension, in the body.

Therapeutic Implications

With its involvement, in both promoting health and causing illness speaking to iNos offers promising chances, for therapy.

  1. Developers are working on creating drugs that specifically target iNos to help manage inflammation and certain types of cancer, with iNos levels while preserving the beneficial roles of eNos and nNos enzymes.
  2. In situations where there is a lack of nitric oxide (NO), like, in some heart conditions; using nitric oxide donors could potentially enhance the function of blood vessels. Increase blood circulation.
  3. Gene therapy methods targeting the regulation of iNOs expression could provide advanced treatment options, for conditions marked by imbalanced nitric oxide production.
  4. Combining iNDOS modulation, with treatment options, like inflammatory drugs or chemotherapy could improve the effectiveness of therapy and lessen potential side effects.

Conclusion

Inducible nitric oxide synthase (known as iNOs or NOS2) is an enzyme involved in the body’s response, by producing nitric oxide—a key player in fighting off infections and diseases successfully. It is crucial for protecting the body from invaders; however wrong iNos levels can result in inflammation damage, to tissues and a range of illnesses.

Suitable ELISA Kits

Online Enquiry Form

"*" indicates required fields

Please check mark information required:

TESTIMONIALS arrow icon

Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford